BR112012006453A2 - dispositivo de hemostasia de compósito em camadas - Google Patents

dispositivo de hemostasia de compósito em camadas

Info

Publication number
BR112012006453A2
BR112012006453A2 BR112012006453A BR112012006453A BR112012006453A2 BR 112012006453 A2 BR112012006453 A2 BR 112012006453A2 BR 112012006453 A BR112012006453 A BR 112012006453A BR 112012006453 A BR112012006453 A BR 112012006453A BR 112012006453 A2 BR112012006453 A2 BR 112012006453A2
Authority
BR
Brazil
Prior art keywords
bioabsorbable
substrate
polymer
layered composite
hemostasis device
Prior art date
Application number
BR112012006453A
Other languages
English (en)
Other versions
BR112012006453B1 (pt
Inventor
Sasa Andjelic
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43756829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012006453(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of BR112012006453A2 publication Critical patent/BR112012006453A2/pt
Publication of BR112012006453B1 publication Critical patent/BR112012006453B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
    • A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

dispositivo de hemostasia de compósito em camadas. a presente invenção refere-se a uma estrutura compósita hemostática tendo um substrato de tecido ou não tecido bioabsorvível que tem pelo menos duas áreas de superfícies principais opostas uma à outra eum filme à base de polímero não poroso e contínuo que é laminado em uma superfície principal do dito substrato. o substrato de tecido bioabsorvível pode ser um polissacarídeo oxidado e/ou o substrato de não tecido pode ser feito de polímeiros não derivados de celulose bioabsorvíveis. o filme à base de polímero não poroso e contínuo pode ser um polímero bioabsorvível. a presente invenção refere-se também a um método para fornecer hemostasia pela aplicação deuma estrutura compósita conforme descrita aqui em um local de ferimento que precisa de um dispositivo hemostático, sendo que uma superfície principal do substrato sem a camada de filme é aplicada no local do ferimento.
BR112012006453-3A 2009-09-22 2010-09-10 Estrutura compósita hemostática e método de fornecer hemostasia BR112012006453B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/564,298 2009-09-22
US12/564,298 US8349354B2 (en) 2009-09-22 2009-09-22 Composite layered hemostasis device
PCT/US2010/048336 WO2011037760A2 (en) 2009-09-22 2010-09-10 Composite layered hemostasis device

Publications (2)

Publication Number Publication Date
BR112012006453A2 true BR112012006453A2 (pt) 2015-09-08
BR112012006453B1 BR112012006453B1 (pt) 2018-08-07

Family

ID=43756829

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012006453-3A BR112012006453B1 (pt) 2009-09-22 2010-09-10 Estrutura compósita hemostática e método de fornecer hemostasia

Country Status (12)

Country Link
US (1) US8349354B2 (pt)
EP (1) EP2480260B1 (pt)
JP (1) JP5749271B2 (pt)
CN (1) CN102630169B (pt)
AU (1) AU2010298598B2 (pt)
BR (1) BR112012006453B1 (pt)
CA (1) CA2774945C (pt)
ES (1) ES2573699T3 (pt)
IN (1) IN2012DN02491A (pt)
MX (1) MX2012003455A (pt)
RU (1) RU2565431C2 (pt)
WO (1) WO2011037760A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8044234B2 (en) * 2005-05-05 2011-10-25 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US20090177226A1 (en) * 2005-05-05 2009-07-09 Jon Reinprecht Bioabsorbable Surgical Compositions
US20100012703A1 (en) * 2005-05-05 2010-01-21 Allison Calabrese Surgical Gasket
US20100016888A1 (en) * 2005-05-05 2010-01-21 Allison Calabrese Surgical Gasket
US20100100124A1 (en) * 2005-05-05 2010-04-22 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US9889230B2 (en) * 2008-10-17 2018-02-13 Covidien Lp Hemostatic implant
US20100100123A1 (en) * 2008-10-17 2010-04-22 Confluent Surgical, Inc. Hemostatic implant
US9592108B2 (en) * 2009-07-29 2017-03-14 Covidien Lp System and method of laparoscopic use of hemostatic patch
EP2563416B1 (en) * 2010-04-30 2016-11-09 Sofradim Production Cellulose-containing medical device having a multi-layer structure produced without adhesive
US8302323B2 (en) 2010-06-21 2012-11-06 Confluent Surgical, Inc. Hemostatic patch
US20120115384A1 (en) 2010-11-10 2012-05-10 Fitz Benjamin D Resorbable Laparoscopically Deployable Hemostat
EP2793968A1 (en) * 2011-12-22 2014-10-29 Janssen Biotech, Inc. Multilayer polymeric drug delivery system
KR102259117B1 (ko) * 2012-05-14 2021-05-31 데이진 가부시키가이샤 시트 성형체 및 지혈재
JP5933365B2 (ja) * 2012-06-22 2016-06-08 帝人株式会社 シート状止血材
EP2759305A1 (en) * 2013-01-24 2014-07-30 Thrombotargets Europe, S.L. Hemostatic compositions
US10765774B2 (en) 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
US11382731B2 (en) 2015-02-27 2022-07-12 Covidien Lp Medical devices with sealing properties
KR101878774B1 (ko) * 2015-04-15 2018-07-17 주식회사 삼양바이오팜 다기능성 지혈제 및 그 제조 방법
AU2016348312B2 (en) * 2015-11-06 2020-09-10 Ethicon, Inc. Compacted hemostatic cellulosic aggregates
CN107281553A (zh) * 2016-03-31 2017-10-24 伏卫霞 贴覆式可吸收医用复合组织材料
US10245817B2 (en) 2016-09-16 2019-04-02 Ethicon, Inc. Method of laminating absorbable semi-crystalline polymeric films
WO2018061323A1 (ja) * 2016-09-30 2018-04-05 株式会社ジーシー 生体吸収性膜の製造方法及び生体吸収性膜
CA3104840A1 (en) * 2018-07-05 2020-01-09 Teijin Pharma Limited Endoscope hemostatic material
US20210252185A1 (en) * 2020-02-18 2021-08-19 Ethicon, Inc. Melt Blown Dressing with Gradient Density
US20210379237A1 (en) * 2020-06-08 2021-12-09 Ethicon, Inc. Napped Coated Wound Dressing
WO2022169911A1 (en) * 2021-02-03 2022-08-11 Datascope Corp. Laminated collagen material and process for producing same

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
BE610364A (fr) 1960-12-01 1962-05-16 Grace W R & Co Perfectionnements à la production de polyoxyméthylène.
US3997512A (en) * 1973-11-21 1976-12-14 American Cyanamid Company High molecular weight polyester resin, the method of making the same
AR205997A1 (es) * 1973-11-21 1976-06-23 American Cyanamid Co Resina de poliester normalmente solida biodegradable e hidrolizable
US4626253A (en) * 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5002551A (en) * 1985-08-22 1991-03-26 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US5007916A (en) * 1985-08-22 1991-04-16 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
GB8818114D0 (en) * 1988-07-29 1988-09-01 Johnson & Johnson Haemostatic wound dressing material
US5180398A (en) * 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
CA2114290C (en) 1993-01-27 2006-01-10 Nagabushanam Totakura Post-surgical anti-adhesion device
IN192791B (pt) * 1996-06-28 2004-05-22 Johnson & Johnson Medical
US6500777B1 (en) * 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
JP2002263117A (ja) * 2001-03-07 2002-09-17 Meiwa Gravure Co Ltd 吸液性シート
RU2228768C2 (ru) * 2001-08-07 2004-05-20 Махмутов Фаниль Ахатович Многослойная медицинская пленка
US7279177B2 (en) * 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
CN1809390B (zh) * 2003-06-26 2010-11-17 株式会社瑞光 创伤覆盖材料和创伤覆盖材料成套器具
US20050113849A1 (en) * 2003-11-26 2005-05-26 Nicholas Popadiuk Prosthetic repair device
US7754233B2 (en) * 2004-09-03 2010-07-13 Ethicon, Inc. Method of preventing post-operative surgical adhesion
EP2345430B1 (en) * 2004-10-20 2015-11-25 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture
US20060258995A1 (en) * 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
US20060257457A1 (en) * 2004-10-20 2006-11-16 Gorman Anne J Method for making a reinforced absorbable multilayered hemostatic wound dressing
WO2006044882A2 (en) * 2004-10-20 2006-04-27 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
KR100785378B1 (ko) * 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
JP2007125155A (ja) * 2005-11-02 2007-05-24 Meditech:Kk 血液拡散機能及び血液吸収機能を有する止血用具
GB2433029A (en) * 2005-12-09 2007-06-13 Ethicon Inc Wound dressings comprising oxidized cellulose and human recombinant collagen
US20070149640A1 (en) * 2005-12-28 2007-06-28 Sasa Andjelic Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates
US8236904B2 (en) * 2005-12-28 2012-08-07 Ethicon, Inc. Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates
WO2007095005A1 (en) 2006-02-10 2007-08-23 Z-Medica Corporation Agents and devices for providing blood clotting functions to wounds
KR101321724B1 (ko) * 2006-04-10 2013-10-29 옴릭스 바이오파마슈티칼, 인코포레이티드 흡수성이 강화된 지혈용 다층 상처 드레싱 및 이의 제조방법
US7652127B2 (en) * 2006-10-31 2010-01-26 Ethicon, Inc. Absorbable copolyesters of poly(ethoxyethylene diglycolate) and glycolide
US7968656B2 (en) * 2006-10-31 2011-06-28 Ethicon, Inc. Absorbable copolyesters of poly(ethoxyethylene diglycolate) and glycolide
US8932619B2 (en) 2007-06-27 2015-01-13 Sofradim Production Dural repair material
US20090004455A1 (en) 2007-06-27 2009-01-01 Philippe Gravagna Reinforced composite implant
JP5192254B2 (ja) * 2008-02-08 2013-05-08 一般財団法人化学及血清療法研究所 シート状組織接着剤

Also Published As

Publication number Publication date
EP2480260B1 (en) 2016-03-02
RU2012116082A (ru) 2013-10-27
IN2012DN02491A (pt) 2015-08-28
CN102630169B (zh) 2014-12-17
CA2774945A1 (en) 2011-03-31
EP2480260A4 (en) 2013-12-18
WO2011037760A2 (en) 2011-03-31
AU2010298598B2 (en) 2014-10-16
MX2012003455A (es) 2012-04-20
CA2774945C (en) 2020-05-05
US20110070288A1 (en) 2011-03-24
AU2010298598A1 (en) 2012-04-12
JP5749271B2 (ja) 2015-07-15
JP2013505109A (ja) 2013-02-14
CN102630169A (zh) 2012-08-08
BR112012006453B1 (pt) 2018-08-07
RU2565431C2 (ru) 2015-10-20
WO2011037760A3 (en) 2011-06-09
US8349354B2 (en) 2013-01-08
ES2573699T3 (es) 2016-06-09
EP2480260A2 (en) 2012-08-01

Similar Documents

Publication Publication Date Title
BR112012006453A2 (pt) dispositivo de hemostasia de compósito em camadas
BR112019025025A2 (pt) Penso para tratar um sítio de tecido com pressão negativa, sistema para tratar tecido com pressão negativa, método para tratar um ferimento com pressão negativa, uso dos mesmos, e sistemas, aparelhos e metodos
BR112016028274A2 (pt) filmes em multicamadas de polímeros termoplásticos compreendendo poli(ácido láctico)
EP2571466A4 (en) REINFORCED MULTILAYER ABSORBABLE FIBER FOR BLOOD-TREATMENT APPLICATIONS
BR112017013199A2 (pt) filme respirável monolítico e compósito fabricado a partir do mesmo
WO2012112417A3 (en) Tissue grafts modified with a cross-linking agent and method of making and using the same
ATE485787T1 (de) Verbesserte op-abdecktücher mit fenster
BR112015005310A2 (pt) estrutura em multicamada
WO2008076535A3 (en) Multi-layer films comprising propylene-based polymers
BR112017004167A2 (pt) camada de intercalação para vidro laminado e vidro laminado
EP2740592A3 (de) Mehrschichtige Folie
BR112017014153A2 (pt) técnicas de revestimento de barreira de gás e artigos produzidos a partir das mesmas
BR112018007902A2 (pt) componente compósito, turbina eólica, e, método para produzir um componente compósito.
BR112013007068A2 (pt) película com múltiplas camadas para a embalagem resselável
BR112014003658A2 (pt) estruturas de polímero em multicamadas
ATE537700T1 (de) Landwirtschaftliche sperrfolien mit hervorragender reissfestigkeit
BR112018001574A2 (pt) laminados elásticos, método de fabricação dos mesmos e artigos compreendendo os mesmos
JP2017522210A5 (pt)
BR112017003217A2 (pt) estrutura têxtil para impedir a penetração e propagação de água nos cabos
GB0908036D0 (en) Pressure actuator
BR112015031629A2 (pt) filme multicamadas coextrudado com polímero baseado em propileno e polímero baseado em etileno
DE102015000255A1 (de) Decklage, Dämmplatte und Wärme-Dämm-Verbundsystem
BR112019024005A2 (pt) material nanocompósito elástico de múltiplas camadas, materiais de revestimento, revestimento, estrutura de transformação, estrutura implementável e estrutura
EP2388389A3 (de) Dampfisolierende Wandverkleidung
RU73273U1 (ru) Изоляционный материал

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2739 DE 04-07-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.